CHTOP is a novel therapeutic target for chemoresistant epithelial ovarian cancer therapy

被引：0
|
作者：
Bai, Xupeng [1 ]
Feng, Xiaojie [1 ]
Ni, Jie [1 ]
Beretov, Julia [1 ]
Deng, Junli [1 ]
Zhu, Ying [1 ]
Graham, Peter [1 ]
Li, Yong [1 ]
机构：
[1] Univ New South Wales, Kogarah, NSW, Australia
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
ovarian cancer; chemoresistance; CHTOP; metastasis; apoptosis; stemness;
D O I：
10.1158/1538-7445.SABCS18-4754
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4754
引用
收藏
页数：2
相关论文
共 50 条
  • [1] CHTOP in Chemoresistant Epithelial Ovarian Cancer: A Novel and Potential Therapeutic Target
    Feng, Xiaojie
    Bai, Xupeng
    Ni, Jie
    Wasinger, Valerie C.
    Beretov, Julia
    Zhu, Ying
    Graham, Peter
    Li, Yong
    [J]. FRONTIERS IN ONCOLOGY, 2019, 9
  • [2] NFKB SIGNALING PATHWAY AS A THERAPEUTIC TARGET IN CHEMORESISTANT OVARIAN CANCER
    Yousefi, H.
    Momeny, M.
    Poursheykhani, A.
    Ghaffari, S. H. A.
    Eyvani, H.
    Zarrinrad, G.
    Barghi, F.
    Sabourinejad, Z.
    Esmaili, F.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1727 - 1727
  • [3] Epithelial Membrane Protein-2 Is a Novel Therapeutic Target in Ovarian Cancer
    Fu, Maoyong
    Maresh, Erin L.
    Soslow, Robert A.
    Alavi, Mohammad
    Mah, Vei
    Zhou, Qin
    Iasonos, Alexia
    Goodglick, Lee
    Gordon, Lynn K.
    Braun, Jonathan
    Wadehra, Madhuri
    [J]. CLINICAL CANCER RESEARCH, 2010, 16 (15) : 3954 - 3963
  • [4] CHEMORESISTANT OVARIAN CANCER STEM CELLS REVEAL NOVEL THERAPEUTIC TARGETS
    Sharrow, Allison C.
    Jones, Richard J.
    Wu, Lily
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (22) : 218 - 218
  • [5] MRPL15 is a novel prognostic biomarker and therapeutic target for epithelial ovarian cancer
    Xu, Haoya
    Zou, Ruoyao
    Li, Feifei
    Liu, Jiyu
    Luan, Nannan
    Wang, Shengke
    Zhu, Liancheng
    [J]. CANCER MEDICINE, 2021, 10 (11): : 3655 - 3673
  • [6] β-catenin as a TIC therapeutic target in epithelial ovarian cancer.
    Nagaraj, Anil Belur
    Joseph, Peronne
    Kovalenko, Olga
    Singh, Sareena
    Armstrong, Amy
    DiFeo, Analisa
    [J]. CLINICAL CANCER RESEARCH, 2016, 22
  • [7] CDK7 is a reliable prognostic factor and novel therapeutic target in epithelial ovarian cancer
    Kim, Jihye
    Cho, Young-Jae
    Ryu, Ji-Yoon
    Hwang, Ilseon
    Han, Hee Dong
    Ahn, Hyung Jun
    Kim, Woo Young
    Cho, Hanbyoul
    Chung, Joon-Yong
    Hewitt, Stephen M.
    Kim, Jae-Hoon
    Kim, Byoung-Gie
    Bae, Duk-Soo
    Choi, Chel Hun
    Lee, Jeong-Won
    [J]. GYNECOLOGIC ONCOLOGY, 2020, 156 (01) : 211 - 221
  • [8] Novel expression of CD11b in epithelial ovarian cancer: Potential therapeutic target
    Saed, Ghassan M.
    Fletcher, Nicole M.
    Diamond, Michael P.
    Morris, Robert T.
    Gomez-Lopez, Nardhy
    Memaj, Ira
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 148 (03) : 567 - 575
  • [9] Notch3 Overexpression as Potential Therapeutic Target in Advanced Stage Chemoresistant Ovarian Cancer
    Rahman, Mohammed Tanjimur
    Nakayama, Kentaro
    Rahman, Munmun
    Katagiri, Hiroshi
    Katagiri, Atsuko
    Ishibashi, Tomoka
    Ishikawa, Masako
    Iida, Kouji
    Nakayama, Satoru
    Otsuki, Yoshiro
    Miyazaki, Kohji
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2012, 138 (04) : 535 - 544
  • [10] Iron addiction: a novel therapeutic target in ovarian cancer
    D Basuli
    L Tesfay
    Z Deng
    B Paul
    Y Yamamoto
    G Ning
    W Xian
    F McKeon
    M Lynch
    C P Crum
    P Hegde
    M Brewer
    X Wang
    L D Miller
    N Dyment
    F M Torti
    S V Torti
    [J]. Oncogene, 2017, 36 : 4089 - 4099
12345